Skip to main content

Vanderbilt Heart and Vascular Institute Archives

Anticoagulation Clinic at Vanderbilt Heart designated an Anticoagulation Center of Excellence

Jun. 9, 2021—The Anticoagulation Clinic at Vanderbilt Heart and Vascular Institute (VHVI) has been designated an Anticoagulation Center of Excellence by the Anticoagulation Forum, one of only three in Tennessee.

Read more


New Clinician Spotlight: Matthews Chacko

Apr. 8, 2021—Matthews Chacko, MD, has joined Vanderbilt Heart and Vascular Institute as an assistant professor of Medicine, an interventional cardiologist and the director of peripheral vascular interventions.

Read more


Murfreesboro heart clinic reveals power of diversity

Mar. 10, 2021—In suburban Murfreesboro, just a short drive off Interstate 24, is one of the most diverse practices and clinics in Vanderbilt Health.

Read more


Congenital Heart Program gains accreditation from ACHA

Jan. 21, 2021—The Adult Congenital Heart Association (ACHA) has awarded the Vanderbilt Adult Congenital Heart Program status as an Adult Congenital Heart Disease (ACHD) Accredited Comprehensive Care Center — the first in Tennessee.

Read more


Freedman named director of the Division of Cardiovascular Medicine

Jan. 7, 2021—Jane Freedman, MD, will join Vanderbilt University Medical Center as director of the Division of Cardiovascular Medicine and the physician-in-chief of the Vanderbilt Heart and Vascular Institute, effective Aug. 1.

Read more


Muñoz named to key VHVI leadership role

Dec. 17, 2020—Daniel Muñoz, MD, MPA, associate professor of Medicine, has been named the new executive medical director of the Patient Care Center (PCC) at Vanderbilt Heart and Vascular Institute (VHVI), effective Jan. 1, 2021.

Read more


VHVI’s Brown, Agrawal receive American Heart Association awards

Dec. 10, 2020—Two Vanderbilt Heart and Vascular Institute researchers are receiving awards from the American Heart Association.

Read more


Minimally invasive treatment option for AFib studied

Oct. 22, 2020—A minimally invasive procedure that combines ligation of the left atrial appendage (LAA) with hybrid epicardial-endocardial ablation is a feasible, safe and effective method of treating patients with longstanding atrial fibrillation (AF or AFib), according to a new Vanderbilt-led study.

Read more


New device may aid advanced heart failure patients

Sep. 17, 2020—Vanderbilt Heart and Vascular Institute (VHVI) has implanted its first V-Wave, an interatrial shunt device, as a part of a multi-center clinical trial.

Read more


Keith Churchwell, MD, appointed president of Yale New Haven Hospital

Aug. 4, 2020—Former Vanderbilt cardiology leader Keith Churchwell, MD, has been appointed president of Yale New Haven Hospital (YNHH) in Connecticut.

Read more


Device allows VHVI doctors to monitor heart patients remotely

Jul. 30, 2020—In 2018, Ronnie Kreis began to develop severe heart failure. After being hospitalized multiple times that year near his home in Oliver Springs in East Tennessee, he was told that nothing else could be done.

Read more


Ventricular assist device program hits major milestone

May. 6, 2020—VHVI’s cardiac surgery and heart failure teams recently celebrated a milestone — implanting the 500th adult patient with a ventricular assist device.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more